HCA Healthcare, Inc. - Form 8-K Filing

This filing reports that Dr. Michael Cuffe will be stepping down as Executive Vice President and Chief Clinical Officer of HCA Healthcare, Inc. effective August 31, 2026. He will transition to a different role within the company until February 2027. Dr. Cuffe will receive benefits in line with the company's executive severance policy and incentive plans. The report was filed on June 18, 2026, and the earliest event reported is June 15, 2026. HCA Healthcare, Inc. is incorporated in Delaware and its common stock is traded on the New York Stock Exchange under the symbol HCA.